Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-04-18 00:00:00 ET · period of report 2024-04-15 · accession 0001628280-24-016673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-18 | 2024-04-15 | BLFS | Berard Todd | CMO | S - Sale | $15.67 | -10.0K | 129.6K | -7% | -$156.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-15 | S | D | 10,000 | $15.67 | 129,644 | D | — | — |